PofoliaShared via Pofolia

Journal of Cranio-Maxillofacial Surgery· 2026Q2

Postoperative radiotherapy for early oral squamous cell carcinoma with a single ipsilateral lymph node metastasis — a retrospective cohort study

Amer Ahmad Yousef Alkhateeb, Basim Abu Hawas, Ralph Brinks, Stefan Haßfeld et al.

Short summary

Postoperative radiotherapy (PORT) for early oral squamous cell carcinoma (OSCC) with a single lymph node metastasis (pN1) did not improve overall survival (63% vs 65% at 60 months) or regional recurrence-free survival (30% vs 25% at 60 months) compared to surgery alone (SO) in a cohort of 85 patients.

AI-generated from the title and abstract; the full text is not read.

Key points

  • PORT did not improve overall survival (63% vs 65% at 60 months) or regional recurrence-free survival (30% vs 25% at 60 months) in early OSCC with pN1 disease compared to surgery alone.
  • Adjusted Cox regression showed no significant association between PORT and improved OS (HR 0.94) or R-RFS (HR 0.81).
  • Factors predicting PORT use included poor differentiation, high-risk margins, and bilateral neck dissection.
  • Potential benefits of PORT were observed in subgroups with pT2 tumors, age under 70, and inadequate neck dissection (<18 nodes).

AI-generated from the title and abstract; the full text is not read.

Abstract

Background/aims Managing early oral squamous cell carcinoma (OSCC) with a solitary ipsilateral lymph node metastasis (pN1) and no additional adverse features remains controversial, with conflicting international guidelines. Our study examined the effect of postoperative radiotherapy (PORT) compared with surgery only (SO) on several survival outcomes in a clinical cohort. Methods Patients diagnosed with a primary pT1–2 OSCC and a single ipsilateral lymph node metastasis (pN1) without an extranodal extension were retrospectively identified. Factors associated with receiving PORT were assessed using logistic regression. Adjusted Cox regression models were used to examine the association between PORT and overall survival (OS) and regional recurrence-free survival (R-RFS) in the whole cohort and in different subgroups. Results In total, 85 patients were included in our study, of whom 43 received PORT. Three factors were predictors of receiving PORT in our cohort, namely: poor differentiation, high-risk margins, and bilateral neck dissection. Overall survival and probability of regional recurrence after 60 months were comparable between groups: 63% and 30% in the SO group and 65% and 25% in the PORT group, respectively. After adjusting for established confounders, PORT was not associated with improved OS HR (PORT vs SO = 0.94; 95% CI 0.46–1.92; p = 0.9) nor with improved regional recurrence-free survival (PORT vs SO = 0.81; 95% CI 0.30–2.17; p = 0.7. Subgroup analyses revealed potential benefit from PORT in patients with pT2 tumors, age under 70 years, and inadequate neck dissection (lymph node yield < 18 nodes). Conclusion While registry-based studies often lack granular data on comorbidities and specific recurrence types, our results suggest that the marginal gains of PORT may not justify its high morbidity, including significant long-term impacts on quality of life. Observation seems to be a safe alternative to routine irradiation in carefully selected pT1–2 pN1 OSCC cases, provided surgical neck management is adequate.

The authors' abstract, as published at the source. Journal of Cranio-Maxillofacial Surgery, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Otorhinolaryngology

OtorhinolaryngologyMedicine